NCT05695495View on ClinicalTrials.gov

Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study)

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

February 2, 2025

Study Completion Date

March 4, 2025

Conditions
Healthy
Interventions
DRUG

N,N-Dimethyltryptamine (5mg)

Intravenous bolus application over 45 seconds

DRUG

N,N-Dimethyltryptamine (10mg)

Intravenous bolus application over 45 seconds

DRUG

N,N-Dimethyltryptamine (15mg)

Intravenous bolus application over 45 seconds

DRUG

N,N-Dimethyltryptamine (20mg)

Intravenous bolus application over 45 seconds

DRUG

N,N-Dimethyltryptamine (25mg)

Intravenous bolus application over 45 seconds

DRUG

Placebo (saline)

Intravenous bolus application over 45 seconds

Trial Locations (1)

4056

Clinical Pharmacology & Toxicology, University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT05695495 - Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study) | Biotech Hunter | Biotech Hunter